Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs intravenous vs topical tranexamic acid for bleeding reduction after total knee arthroplasty
IRCT20180411039272N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of tranexamic acid in Bleeding (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Mean postoperative hemorrhage, Mean intraoperative hemorrhage and 2 more. Started Apr 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on IRCT20180411039272N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180411039272N1.